Cargando…

The Korean Clinical Research Center for End-Stage Renal Disease Study Validates the Association of Hemoglobin and Erythropoiesis-Stimulating Agent Dose with Mortality in Hemodialysis Patients

BACKGROUND: Anemia is an important risk factor for mortality in hemodialysis (HD) patients. However, higher hemoglobin (Hb) is not necessarily better, as seen in several studies. This study aimed to validate the clinical use of an Hb target of 10–11 g/dL in Korean HD patients. METHODS: A total of 1,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Owen, Jang, Hye Min, Jung, Hee-Yeon, Kim, Yon Su, Kang, Shin-Wook, Yang, Chul Woo, Kim, Nam-Ho, Choi, Ji-Young, Cho, Jang-Hee, Kim, Chan-Duck, Kim, Yong-Lim, Park, Sun-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599895/ https://www.ncbi.nlm.nih.gov/pubmed/26452232 http://dx.doi.org/10.1371/journal.pone.0140241

Ejemplares similares

Medium cut-off dialyzer improves erythropoiesis stimulating agent resistance in a hepcidin-independent manner in maintenance hemodialysis patients: results from a randomized controlled trial
por: Lim, Jeong-Hoon, et al.
Publicado: (2020)

Use of erythropoiesis-stimulating agents in obese hemodialysis patients
por: Park, Sun-Hee
Publicado: (2018)

Survival in patients on hemodialysis: Effect of gender according to body mass index and creatinine
por: Park, Jeung-Min, et al.
Publicado: (2018)

Survival Advantage of Peritoneal Dialysis Relative to Hemodialysis in the Early Period of Incident Dialysis Patients: A Nationwide Prospective Propensity-Matched Study in Korea
por: Choi, Ji-Young, et al.
Publicado: (2013)

The benefit of planned dialysis to early survival on hemodialysis versus peritoneal dialysis: a nationwide prospective multicenter study in Korea
por: Lim, Jeong-Hoon, et al.
Publicado: (2023)

Better Quality of Life of Peritoneal Dialysis compared to Hemodialysis over a Two-year Period after Dialysis Initiation
por: Jung, Hee-Yeon, et al.
Publicado: (2019)

Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study
por: Kwon, Eugene, et al.
Publicado: (2015)

Free Thyroxine Level as an Independent Predictor of Infection-Related Mortality in Patients on Peritoneal Dialysis: A Prospective Multicenter Cohort Study
por: Jung, Hee-Yeon, et al.
Publicado: (2014)

Implications of a Reduction in the Hemoglobin Target in Erythropoiesis-Stimulating Agent-Treated Hemodialysis Patients
por: Nguyen, Timothy V., et al.
Publicado: (2011)

The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
por: Sibbel, Scott, et al.
Publicado: (2016)

Individualized prediction of mortality using multiple inflammatory markers in patients on dialysis
por: Jung, Hee-Yeon, et al.
Publicado: (2018)

Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
por: Haase, Volker H, et al.
Publicado: (2019)

Resistance to Erythropoiesis-Stimulating Agents Is Associated with Arterial Microcalcification in Early Hemodialysis Patients
por: Won, Hye Sung, et al.
Publicado: (2014)

COVID-19–related clinical outcomes among Korean hemodialysis patients
por: Park, Hayne Cho, et al.
Publicado: (2022)

Comparison of Patient Survival According to Erythropoiesis-Stimulating Agent Type of Treatment in Maintenance Hemodialysis Patients
por: Kang, Seok Hui, et al.
Publicado: (2023)

Survival predictors in anuric patients on peritoneal dialysis: A prospective, multicenter, propensity score-matched cohort study
por: Park, Ja-Yong, et al.
Publicado: (2018)

Graves’ Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study
por: Cho, Yoon Young, et al.
Publicado: (2022)

Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study
por: Lee, Ji-Eun, et al.
Publicado: (2017)

Comparison between short- and long-acting erythropoiesis-stimulating agents in hemodialysis patients: target hemoglobin, variability, and outcome
por: Bernieh, Bassam, et al.
Publicado: (2014)

The differential effects of anemia on mortality in young and elderly end-stage renal disease patients
por: Ko, Eun Jeong, et al.
Publicado: (2020)

Dialysis modality-related disparities in sudden cardiac death: hemodialysis versus peritoneal dialysis
por: Jung, Hee-Yeon, et al.
Publicado: (2019)

Recalibration and Validation of the Charlson Comorbidity Index in Korean Incident Hemodialysis Patients
por: Park, Jae Yoon, et al.
Publicado: (2015)

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Bae, Myoung Nam, et al.
Publicado: (2015)

Erythropoiesis-stimulating Agents and Anemia in Patients with Non-dialytic Chronic Kidney Disease
por: Kim, Sun Moon, et al.
Publicado: (2016)

Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients
por: Gupta, Ajay, et al.
Publicado: (2015)

Factors Affecting Selection of a Dialysis Modality in Elderly Patients With Chronic Kidney Disease: A Prospective Cohort Study in Korea
por: Cho, Jang-Hee, et al.
Publicado: (2022)

Prediction of hemoglobin levels in individual hemodialysis patients by means of a mathematical model of erythropoiesis
por: Fuertinger, Doris H., et al.
Publicado: (2018)

Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus
por: Kim, Bo-Yeon, et al.
Publicado: (2011)

Platelet activity with hemoglobin level in patients with hemodialysis: Prospective study
por: Kim, Jae Min, et al.
Publicado: (2020)

Sex disparities in mortality among patients with kidney failure receiving dialysis
por: Jung, Hee-Yeon, et al.
Publicado: (2022)

Impact of dialysis modality on technique survival in end-stage renal disease patients
por: Lee, Jong-Hak, et al.
Publicado: (2016)

Clinical Effectiveness and Safety of Remdesivir in Hemodialysis Patients with COVID-19
por: Lim, Jeong-Hoon, et al.
Publicado: (2022)

Mechanisms of hemoglobin cycling in anemia patients treated with erythropoiesis-stimulating agents
por: Jörg, David J., et al.
Publicado: (2023)

Selenium Associates With Response to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
por: Yasukawa, Minoru, et al.
Publicado: (2022)

Parathyroidectomy Improves the Consumption of Erythropoiesis-Stimulating Agents in Hemodialysis Patients
por: Lee, Yu-Ting, et al.
Publicado: (2022)

Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea
por: Jung, Hee-Yeon, et al.
Publicado: (2020)

Hemoglobin Kansas: First Korean Family and Literature Review
por: Jo, Irene, et al.
Publicado: (2017)

Successful provision of hemodialysis to patients with confirmed COVID-19 in Korea: the role of a cooperative network between public and private medical systems
por: Choi, Ji-Young, et al.
Publicado: (2022)

Maternal and neonatal outcomes in Korean women with type 2 diabetes
por: Jang, Hye-Jung, et al.
Publicado: (2018)

Hemoglobin decline in cancer patients receiving chemotherapy without an erythropoiesis-stimulating agent
por: Pirker, Robert, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kn1t2jgvsi61okq1pv7j7h38km